Alper Can
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
-
- Gastric Cancer Management and Outcomes
- Renal cell carcinoma treatment
- Brain Metastases and Treatment
Papers in
- Oncology 19
- Cancer Diagnosis and Treatment 5
- Colorectal Cancer Treatments and Studies 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Lung Cancer Research Studies 3
-
- Metastasis and carcinoma case studies 3
- Gastric Cancer Management and Outcomes 3
- Co-authors
- İbrahim Vedat Bayoğlu (26 shared papers)Lütfiye Demir (25 shared papers)Ahmet Dirican (24 shared papers)Yüksel Küçükzeybek (24 shared papers)Çiğdem Erten (22 shared papers)Mustafa Oktay Tarhan (20 shared papers)Işıl Somali (19 shared papers)Murat Akyol (20 shared papers)
- Journals
- Clinical & Experimental Metastasis (2 papers)Cancer Biomarkers (1 paper)Clinical Genitourinary Cancer (1 paper)The Breast Journal (1 paper)Journal of Surgical Oncology (1 paper)
- Partner nations
- TürkiyeKazakhstanGermany
In The Last Decade
Alper Can
29 papers receiving 333 citations
Peers
Comparison fields: 5 of 48
- Oncology 228
- Pulmonary and Respiratory Medicine 146
- Cancer Research 60
- Gastroenterology 17
- Hepatology 22
Countries citing papers authored by Alper Can
This map shows the geographic impact of Alper Can's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alper Can with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alper Can more than expected).
Fields of papers citing papers by Alper Can
This network shows the impact of papers produced by Alper Can. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alper Can. The network helps show where Alper Can may publish in the future.
Co-authors
The 25 scholars most cited alongside Alper Can, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 50 | |
| 2 | 2013 | 31 | |
| 3 | 2013 | 26 | |
| 4 | 2013 | 25 | |
| 5 | 2014 | 25 | |
| 6 | 2014 | 20 | |
| 7 | 2014 | 20 | |
| 8 | 2012 | 19 | |
| 9 | 2012 | 17 | |
| 10 | The association of hematologic parameters on the prognosis of patients with metastatic renal cell carcinoma. | 2013 | 16 |
| 11 | 2013 | 15 | |
| 12 | 2013 | 11 | |
| 13 | The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. | 2017 | 8 |
| 14 | 2005 | 7 | |
| 15 | The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients. | 2014 | 6 |
| 16 | 2012 | 5 | |
| 17 | 2015 | 4 | |
| 18 | 2014 | 4 | |
| 19 | 2014 | 4 | |
| 20 | 2012 | 3 |
About Alper Can
Alper Can is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Rheumatology and Epidemiology, having authored 29 papers that have together received 338 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Metastasis and carcinoma case studies (3 papers), Gastric Cancer Management and Outcomes (3 papers), Lung Cancer Research Studies (3 papers), Colorectal and Anal Carcinomas (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Oncology (228 citations), Pulmonary and Respiratory Medicine (146 citations), Cancer Research (60 citations), Gastroenterology (17 citations) and Hepatology (22 citations). Alper Can has collaborated with scholars based in Türkiye, Kazakhstan and Germany. Frequent co-authors include İbrahim Vedat Bayoğlu, Lütfiye Demir, Ahmet Dirican, Yüksel Küçükzeybek, Çiğdem Erten, Mustafa Oktay Tarhan, Işıl Somali, Murat Akyol, Ahmet Alacacıoğlu and Suna Çokmert. Their work appears in journals such as Clinical & Experimental Metastasis, Cancer Biomarkers, Clinical Genitourinary Cancer, The Breast Journal and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.